Quick Answer
Indaptus Therapeutics, Inc. reported Total Assets of $9.31 million for fiscal year 2025.
Indaptus Therapeutics, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $9.31M | +26.9% |
| 2024 | $7.34M | -50.8% |
| 2023 | $14.92M | -46.8% |
| 2022 | $28.06M | -30.8% |
| 2021 | $40.58M | +2182.4% |
| 2020 | $1.78M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $6.84M | -17.0% | +0.0% |
| June 30, 2025 | $6.84M | -15.8% | +26.4% |
| March 31, 2025 | $5.41M | -50.6% | -26.3% |
| December 31, 2024 | $7.34M | -50.8% | -10.9% |
| September 30, 2024 | $8.24M | -53.7% | +1.5% |
| June 30, 2024 | $8.12M | -61.0% | -25.8% |
| March 31, 2024 | $10.95M | -52.7% | -26.6% |
| December 31, 2023 | $14.92M | -46.8% | -16.1% |
- Indaptus Therapeutics, Inc. showed an increase of +26.9% in Total Assets compared to the prior fiscal year.
- Over the 2020–2025 period, Indaptus Therapeutics, Inc.’s total assets has grown by 423.7% (from $1.78 million to $9.31 million).
- The most recent figure is from Indaptus Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 17, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: